Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions are present. And that's precisely what these companies have seen over recent months thanks to strong quarterly results.
Philip Morris International PM continues to lean on pricing as a key earnings driver. The company delivered a strong first quarter of 2025, with adjusted earnings per share (EPS) rising 12.7% year over year to $1.69.
Asking for a Trend anchor Josh Lipton breaks down the latest market trends for June 16, 2025. US stocks close higher on hopes the Israel-Iran conflict remains contained.
Philip Morris International Inc., a leading tobacco company, is committed to becoming a 100% smoke-free entity. By March 2025, 42% of revenue was from smoke-free products like IQOS and ZYN. The firm is advancing digital transformation and tech initiatives to enhance health-focused and prescription products. Philip Morris International Inc., a leading tobacco company, is committed to becoming a 100% smoke-free entity. By March 2025, 42% of revenue was from smoke-free products like IQOS and ZYN. The firm is advancing digital transformation and tech initiatives to enhance health-focused and prescription products.
Philip Moriss is strategically evolving beyond its traditional cigarette business, exemplified by the remarkable success of its "Zyn" oral nicotine patch.
PM sees smoke-free products drive 44% of Q1 profit as ZYN and IQOS momentum redefines its future beyond tobacco.
PM stock soars 50.1% year to date, fueled by smoke-free growth, premium pricing and bullish earnings momentum.
Philip Morris International, Inc. (NYSE:PM ) dbAccess Global Consumer Conference Call June 3, 2025 5:15 AM ET Company Participants Emmanuel Babeau - CFO Conference Call Participants Damian McNeela - Deutsche Bank Damian McNeela Good morning, everybody. I think we will make a start.
Philip Morris is leading the industry transition to smoke-free products, with 42% of revenue now from alternatives like IQOS and Zyn. Strong Q1 2025 results—10.2% organic revenue growth, rising margins, and raised earnings guidance—demonstrate robust financial health and execution. Despite a premium valuation and some regulatory and competitive risks, PM's stable cash flow and dividend growth justify a strong buy rating.
PM's market leadership in the tobacco market across combustible and smoke-free approaches has been well rewarded indeed, as observed in the premium valuations and inflated stock prices. These have been well supported by the growing net revenues, the expanding shipment volumes, and the richer adj operating margins, significantly aided by the US FDA approval for ZYN. This is on top of the rich cash flow story, with PM's dividend remaining safe despite the management's intensified US-based capex thus far.
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock?
PM shows strong growth prospects, driven by its successful shift to smoke-free products, solid first-quarter results and optimistic guidance.